"We make our technical experts truly available to our customers – something they appreciate a lot," Mostafa noted. Related:Samsung Biologics makes bold peptide play with $1.8bn PolyPeptide buyThis shift has profound implications for how KBI approaches every engagement. Edgar reinforced this point: "The transparency you'll get with KBI in early conversations translates down to both organizations. "The challenge is making sure customers understand this. The partnership differenceWhat emerges from KBI's approach is a different conception of what a CDMO can be.